Clinical Trials
3 trialsNCT05559008 2022-11-09
A Umbrella Study in R/R PTCL Guided by Molecular Subtypes
Ruijin Hospital
Phase 1/2 Unknown
NCT04476459 2021-03-15
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
Sun Yat-sen University
Phase 1/2 Unknown
NCT02844881 2016-08-11
Study of Apatinib and MASCT in Patients With Advanced Solid Tumors
The First People's Hospital of Lianyungang
Phase 1/2 Unknown